Table 1.
Investigation panel
| Admission | |
| Haematology | N: blood count except for thrombocytopaenia 35 000 cells/mm3; N: blood times |
| Biochemistry | N: renal function, hepatic function, pH |
| HIV ½ | Indeterminate ELISA, negative Western Blot |
| Urine (drugs of abuse) | Negative |
| CSF | ↑lymphocytes (234 cells), ↑protein (137 mg/dl), N glucose (61 mg/dl) |
| Chest x-ray | Normal |
| Cranial tomography of the brain | Normal |
| 1st/2nd Week | |
| Brain MRI | Normal |
| EEG | Generalised diffuse slowing activity |
| Microbiology (blood/CSF) | Toxoplama, Koch bacillus, Borrelia, Mycoplasma, Adenoviruses, CMV, EBV, HSV, VRDL, HBV, HCV, VRDL/RPR, Enterovirus, JC |
| HIV ½ | Indeterminate ELISA, negative Western Blot |
| 3rd Week | |
| HIV ½ | Positive ELISA and Western Blot |
| Haematology | N: blood count except for thrombocytopaenia 64 000 cells/mm3 |
CMV, cytomegalovirus; CSF, cerebrospinal fluid; EBV, Epstein–Barr virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HSV, herpes simplex virus; JC, John Cunningham; N, normal, RPR, rapid plasma reagin; VDRL, venereal disease research laboratory test; ↑, increased.